Vorlícek J
Interní hematoonkologická klinika Lékarské fakulty MU a FN Brno.
Vnitr Lek. 2004 Oct;50 Suppl 1:S9-22.
The problematics of oncology is staying at the fore of the health problems in our republic. Every third of us falls ill with malignant tumour and every fourth dies of it. There were 37,000 malignant tumours diagnosed in our republic in 1977, in 1999 it was 59,500 and the amount is expected to increase up to 70,000 in 2004. Our results regarding the relative 5-year survival of the patients with all the oncologic diagnoses from 15 to 44 years are below European average. The most frequent tumour is lung cancer and bronchial cancer in males, breast cancer in females and the most frequent malignant tumour in both sexes is the colorectal cancer, the absolute rate of which has unambiguously the leading position. Czech republic stands at the forefront in Europe as for the incidence of all the tumours except the skin tumours. Among all the European males it is just Czech males who have a large probability of colorectal cancer. Moreover, regarding malignant renal cancer our republic is in the first position in both males and females. What do these epidemiologic dates imply? The risk of the development of malignant disease imminently endangers each of us. For Czech republic the malignant disease constitutes a big load as personal hardship and disability, increased need for hospital bed capacities and consequent increased economic costs. In 2003, the Czech oncologic society of Czech medical company of J. E. Purkyne created the National oncologic programme (NOP) of the Czech republic. Further there are named its aims, strategy and tasks. In the conclusion we mention what is the "glamour" and the "poverty" of oncology.
肿瘤学问题一直是我国健康问题的重中之重。我们当中每三个人中就有一人罹患恶性肿瘤,每四个人中就有一人死于恶性肿瘤。1977年,我国共诊断出37000例恶性肿瘤病例;1999年,这一数字为59500例;预计到2004年,这一数字将增至70000例。我们关于15至44岁所有肿瘤诊断患者的相对5年生存率的结果低于欧洲平均水平。男性中最常见的肿瘤是肺癌和支气管癌,女性中是乳腺癌,而男女中最常见的恶性肿瘤是结直肠癌,其绝对发病率无疑占据主导地位。捷克共和国在欧洲除皮肤肿瘤外的所有肿瘤发病率方面位居前列。在所有欧洲男性中,正是捷克男性患结直肠癌的概率很大。此外,在恶性肾癌方面,我国无论男性还是女性都位居首位。这些流行病学数据意味着什么呢?恶性疾病的发展风险时刻威胁着我们每一个人。对捷克共和国来说,恶性疾病给个人带来巨大痛苦和残疾,增加了对医院病床的需求,进而导致经济成本上升,构成了沉重负担。2003年,捷克J.E. 普尔基涅医学公司的捷克肿瘤学会制定了捷克共和国国家肿瘤计划(NOP)。接下来将阐述其目标、战略和任务。在结论部分,我们将提及肿瘤学的“魅力”与“困境”。